792 related articles for article (PubMed ID: 31122190)
1. Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid-femoral pulse wave velocity in hemodialysis patients: a cross sectional study.
Hou JS; Lin YL; Wang CH; Lai YH; Kuo CH; Subeq YM; Hsu BG
BMC Nephrol; 2019 May; 20(1):184. PubMed ID: 31122190
[TBL] [Abstract][Full Text] [Related]
2. Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients.
Pateinakis P; Papagianni A; Douma S; Efstratiadis G; Memmos D
BMC Nephrol; 2013 Jun; 14():122. PubMed ID: 23758931
[TBL] [Abstract][Full Text] [Related]
3. Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients.
Lee JE; Kim HJ; Moon SJ; Nam JS; Kim JK; Kim SK; Yun GY; Ha SK; Park HC
Korean J Intern Med; 2013 Nov; 28(6):668-77. PubMed ID: 24307842
[TBL] [Abstract][Full Text] [Related]
4. High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients.
Hsu BG; Shih MH; Chen YC; Ho GJ; Lin TY; Lee MC
Tohoku J Exp Med; 2015 Aug; 236(4):247-53. PubMed ID: 26156285
[TBL] [Abstract][Full Text] [Related]
5. Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients.
Nakashima A; Carrero JJ; Qureshi AR; Hirai T; Takasugi N; Ueno T; Taniguchi Y; Lindholm B; Yorioka N
Osteoporos Int; 2011 Jun; 22(6):1695-701. PubMed ID: 20812007
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Osteocalcin, Osteoprotegerin and Osteopontin on Arterial Stiffness in Chronic Renal Failure Patients on Hemodialysis.
Csiky B; Sági B; Peti A; Lakatos O; Prémusz V; Sulyok E
Kidney Blood Press Res; 2017; 42(6):1312-1321. PubMed ID: 29258085
[TBL] [Abstract][Full Text] [Related]
7. Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study.
Hsu BG; Liou HH; Lee CJ; Chen YC; Ho GJ; Lee MC
Medicine (Baltimore); 2016 Apr; 95(15):e3300. PubMed ID: 27082570
[TBL] [Abstract][Full Text] [Related]
8. Serum Malondialdehyde-Modified Low-Density Lipoprotein Is a Risk Factor for Central Arterial Stiffness in Maintenance Hemodialysis Patients.
Hou JS; Wang CH; Lai YH; Kuo CH; Lin YL; Hsu BG; Tsai JP
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708072
[TBL] [Abstract][Full Text] [Related]
9. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.
Tousoulis D; Siasos G; Maniatis K; Oikonomou E; Kioufis S; Zaromitidou M; Paraskevopoulos T; Michalea S; Kollia C; Miliou A; Kokkou E; Papavassiliou AG; Stefanadis C
Int J Cardiol; 2013 Sep; 167(5):1924-8. PubMed ID: 22640692
[TBL] [Abstract][Full Text] [Related]
10. Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis.
Serdaroğlu Beyazal M; Erdoğan T; Türkyılmaz AK; Devrimsel G; Cüre MC; Beyazal M; Sahin I
Clin Rheumatol; 2016 Sep; 35(9):2235-41. PubMed ID: 26847856
[TBL] [Abstract][Full Text] [Related]
11. The Correlation of Serum Osteoprotegerin with Non-Traditional Cardiovascular Risk Factors and Arterial Stiffness in Patients with Pre-Dialysis Chronic Kidney Disease: Results from the KNOW-CKD Study.
Chae SY; Chung W; Kim YH; Oh YK; Lee J; Choi KH; Ahn C; Kim YS
J Korean Med Sci; 2018 Dec; 33(53):e322. PubMed ID: 30595681
[TBL] [Abstract][Full Text] [Related]
12. Volume status and arterial blood pressures are associated with arterial stiffness in hemodialysis patients.
Erdan A; Ozkok A; Alpay N; Akkaya V; Yildiz A
Int J Artif Organs; 2018 Jul; 41(7):378-384. PubMed ID: 29806514
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients.
Chang YC; Hsu BG; Liou HH; Lee CJ; Wang JH
BMC Cardiovasc Disord; 2018 Nov; 18(1):214. PubMed ID: 30482161
[TBL] [Abstract][Full Text] [Related]
14. Serum
Lai YH; Wang CH; Kuo CH; Lin YL; Tsai JP; Hsu BG
Toxins (Basel); 2019 Dec; 12(1):. PubMed ID: 31877718
[TBL] [Abstract][Full Text] [Related]
15. Forty-eight-hour ambulatory blood pressure and carotid-femoral pulse wave velocity in hemodialysis patients.
Ekart R; Bernhardt M; Balon BP; Bevc S; Hojs R
Ther Apher Dial; 2011 Jun; 15(3):273-7. PubMed ID: 21624075
[TBL] [Abstract][Full Text] [Related]
16. Bone metabolism regulators and arterial stiffness in postmenopausal women.
Albu A; Fodor D; Bondor C; Crăciun AM
Maturitas; 2013 Oct; 76(2):146-50. PubMed ID: 23916080
[TBL] [Abstract][Full Text] [Related]
17. The ratio of osteoprotegerin to fetuin-a is independently associated with vascular stiffness in hemodialysis patients.
Kim HR; Kim SH; Han MJ; Yoon YS; Oh DJ
Nephron Clin Pract; 2013; 123(3-4):165-72. PubMed ID: 23921088
[TBL] [Abstract][Full Text] [Related]
18. Serum Trimethylamine
Huang PY; Hsu BG; Lai YH; Wang CH; Tsai JP
Toxins (Basel); 2023 Sep; 15(9):. PubMed ID: 37755998
[TBL] [Abstract][Full Text] [Related]
19. Serum Sclerostin But Not DKK-1 Correlated with Central Arterial Stiffness in End Stage Renal Disease Patients.
Wu CF; Hou JS; Wang CH; Lin YL; Lai YH; Kuo CH; Liou HH; Tsai JP; Hsu BG
Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32075016
[TBL] [Abstract][Full Text] [Related]
20. Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease.
Scialla JJ; Leonard MB; Townsend RR; Appel L; Wolf M; Budoff MJ; Chen J; Lustigova E; Gadegbeku CA; Glenn M; Hanish A; Raj D; Rosas SE; Seliger SL; Weir MR; Parekh RS;
Clin J Am Soc Nephrol; 2011 Nov; 6(11):2612-9. PubMed ID: 21940840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
